PRTN3 and rheumatoid arthritis: Importantly, the extensive variable region N-glycosylation seems not to result from random accumulation of mutations, but rather reflects a competitive advantage for survival and differentiation of ACPA-positive B cell clones, allowing them to escape tolerance checkpoints and generate RA-specific autoimmunity (146, 182, 184, 185).